This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Society news


The Learned Society Partnership on Antimicrobial Resistance Statement

27 Sep 2016

The Learned Society Partnership on Antimicrobial Resistance (LeSPAR) welcomes news of global political and pharmaceutical industry support for actions to tackle the threat of resistant infections.   The G7 and G20 summits and the UN General Assembly have now agreed proactive steps to ensure collaboration between nations, accepting the recommendations of the WHO Global Action Plan on AMR and the UK AMR Review.

BJCP article: Study reveals scope and characteristics of adverse drug reactions in the general population

20 Sep 2016

In a study of 1,000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing admission to the hospital was 8.1 percent.

BJP article: Stem cell-based screening methods may predict heart-related side effects of drugs

20 Sep 2016

Coaxing stem cells from patients to become heart cells may help clinicians personalize drug treatments and prevent heart-related toxicity, according to a review in the British Journal of Pharmacology.

British Pharmacological Society signs letter supporting primate research

14 Sep 2016

The British Pharmacological Society is a signatory of a letter in support of primate research, which was published in the Guardian yesterday (13 September) alongside an accompanying article.

Clinical pharmacology debate in the House of Lords

14 Sep 2016

On the evening of 12 September, Lord Hunt of Kings Heath led a debate in the House of Lords, outlining the importance of clinical pharmacologists in the UK and calling for immediate action to tackle the reduction of clinical pharmacologists practicing in the NHS and teaching in universities.

BJCP article: Adverse drug reactions may be under-reported in young children

07 Sep 2016

A new study reveals that adverse drug reactions in newborns and infants may be under-reported.

BJP article: Brain peptide research may lead to promising new treatments for mental illnesses

07 Sep 2016

Recent research points to the importance of a molecule called relaxin-3 in the brain, with effects on various processes and behaviors such as mood, stress, and cognition.

Professor Alan Cuthbert (1932–2016)

06 Sep 2016

The Society is sad to report that Professor Alan Cuthbert died on 27 August after a short illness.

BJCP article: Cardioprotective drug can help prevent long-term heart damage in children who receive chemotherapy

05 Sep 2016

A potent chemotherapy drug can be life saving for children with cancer, but a new review highlights how it can have long-lasting negative effects on the heart. The review, which is published in the British Journal of Clinical Pharmacology, also indicates that this chemotherapy-related heart damage may be prevented by a cardioprotective drug.

BJCP article: Walking a tightrope: Regulators balancing need for safety & flexibility in approvals for new medicines

01 Sep 2016

It can be challenging for regulators to keep up with advances related to medical drugs and devices. A new analysis and editorial published in the British Journal of Clinical Pharmacology provide insights on how officials are working to support accelerated access to new therapies while also ensuring their safety.    

BJCP article: Colour-graded pictogram label to reduce medicine-related traffic crashes found ineffective

22 Aug 2016

A new study questions the effectiveness of using pictogram message on the labels of anxiety and sleep medications that interfere with driving – an approach this is currently implemented across France. The British Journal of Clinical Pharmacology study found that the risk of being responsible for a crash associated with these medicines did not decrease long-term after the pictogram was introduced.